Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can we ablate permanent atrial fibrillation?

G Haywood

    Heart (British Cardiac Society)
    |November 26, 2005
    PubMed
    Summary

    Ablation is increasingly recognized as beneficial for treating drug-resistant atrial fibrillation. This procedure offers a promising option for patients with persistent irregular heart rhythms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical pharmacology of moclobemide, a new reversible monoamine oxidase inhibitor.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis.

    Critical care medicine·2000
    Same author

    Pre-operative assessment of cardiac risk for non-cardiac surgery.

    Journal of the Royal College of Physicians of London·1999
    Same author

    Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation.

    Cardiovascular research·1998
    Same author

    Exercise capacity of heart transplant recipients: the importance of chronotropic incompetence.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·1996
    Same author

    Selecting candidates for cardiac transplantation. How to assess exclusion criteria and predict who will benefit.

    The Journal of critical illness·1995

    Area of Science:

    • Cardiology
    • Electrophysiology
    • Medical Devices

    Background:

    • Atrial fibrillation (AF) is a common arrhythmia.
    • Drug-refractory AF poses significant treatment challenges.
    • Catheter ablation is an established therapeutic option for AF.

    Discussion:

    • Evidence supports the efficacy of ablation in managing drug-refractory atrial fibrillation.
    • Ablation offers a potential curative approach for persistent arrhythmias.
    • Patient selection is crucial for optimizing ablation outcomes.

    Key Insights:

    • Ablation demonstrates growing benefit in treating patients with drug-resistant atrial fibrillation.
    • The procedure targets the source of irregular heart rhythms.
    • Successful ablation can improve quality of life and reduce AF burden.

    Outlook:

    • Further research may refine ablation techniques for complex cases.
    • Expanded use of ablation could become standard for refractory AF.
    • Long-term data will continue to validate ablation's role in AF management.

    Related Experiment Videos